Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study

Anticancer Research

Volumn 23, Issue 2 C, 2003, Pages 1687-1691

  Kalofonos, Haralabos P ^a,b,i   Kardamakis, Dimitrios ^a,b   Bamias, Aristotelis ^a,c   Skarlos, Dimosthenis ^a,d   Papakostas, Pavlos ^a,e   Bafaloukos, Dimitrios ^a,f   Sakantamis, Athanasios ^a,g   Pavlidis, Nicolas ^a,c   Fountzilas, Georgios ^a,h  

^a Hellenic Cooperative Oncology Group   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^d Errikos Dunant Hospital   (Greece)

^e HIPPOKRATION HOSPITAL   (Greece)

^f METAXA CANCER HOSPITAL   (Greece)

^g ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^h ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

ⁱ UNIVERSITY OF PATRAS   (Greece)

Author keywords

Adjuvant chemotherapy; Radiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; ENTERITIS; FATIGUE; FEASIBILITY STUDY; FEMALE; FEVER; HEADACHE; HUMAN; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PAIN; PELVIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CARCINOMA; RECTUM HEMORRHAGE; SALIVATION DISORDER; SKIN DISEASE; THROMBOCYTOPENIA; VERTIGO; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 0038539312     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval on surgically treated rectal carcinoma. N Engl J Med 312: 1465-1472, 1985.
2. Fisher B, Wolmark N, Rockette H et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 80: 21-29, 1988.
3. Krook JE, Moertel CG, Gunderson LL et al: Effective surgical adjuvant therapy for high-risk rectal cancer. N Engl J Med 324: 709-715, 1991.
4. Colorectal Cancer Collaboration Group: Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomized trials. Lancet 358: 1291-1304, 2001.
5. Glimelius B: Chemoradiotherapy for rectal cancer - Is there an optimal combination? Ann Oncol 12: 1039-1045, 2001.
6. Saltz LB, Douillard J, Pirotta N et al: Combined analysis of two phase III randomized trials comparing irinotecan, fluorouracil, leucovorin versus fluorouracil metastatic colorectal cancer. Proc Am Soc Clin Oncol 19: 242a (Abstract), 2000.
7. Douillard JV, Cunningham D, Roth AD et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal carcinoma: a multicenter randomized trial. Lancet 255: 1041-1047, 2000.
8. De Gramont A, Figer A, Seymour M et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938-2947, 2000.
9. Giacchetti S, Perpoint B, Zidani R et al: Phase III multicenter randomized trial oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18: 136-147, 2000.
10. Saltz LB, Cox JV, Blanke C et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal carcinoma. N Engl J Med 343: 905-914, 2000.
11. Freyer G, Bossard N, Romestaing P et al: Addition of Oxaliplatin to continuous fluorouracil L-folinic acid and concomitant radiotherapy in rectal cancer. Thy Lyon R97-03 phase I trial. J Clin Oncol 19: 2433-2438, 2001.
12. Reese T, Tanner J, Frings S et al: Capecitabine combined with simultaneous radiotherapy in rectal cancer: A phase I study. Int J Radiat Oncol Biol Phys 48: 120 (Abstract), 2000.
13. Rosenthal DI, Haller DG, Saltz L et al: Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin. Oncology 14: 59-62, 2000.
14. Greemers GJ, Lund B., Verweij J et al: Topoisomerase I inhibitors: topotecan and irinotecan. Cancer Treat Rev 20: 73-96, 1994.
15. Tsuruo T, Marsuzaki T, Matsushita M et al: Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo. Cancer Chemother Pharmacol 21: 71-74, 1988.
16. Shimada Y, Rougier P and Pitot H: Efficacy of CPT-11 as a single agent in metastatic colorectal cancer. Eur J Cancer 32A: 13-17, 1996.
17. Rougier P and Bugat R: CPT-11 in the treatment of colorectal cancer: Clinical efficacy and safety profile. Sem Oncol 23: (suppl 3) 34-41, 1996.
18. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
19. Bosset J-F, Mantion G, Lorchel F et al: Adjuvant and neoadjuvant radiation therapy for rectal cancer. Sem Oncol 27: (suppl 10) 60-65, 2000.
20. Minsky BD, O'Reilly E, Wong D et al: Daily low-dose irinotecan plus pelvic irradiation as preoperative treatment of locally advanced rectal cancer. Proc Am Soc Clin Oncol 18: 1023 (Abstract), 1999.
21. Klautke G, Kirchner R, Hopt U et al: Continuous infusion of 5-fluorouracil and weekly irinotecan with concurrent radiotherapy as neoadjuvant treatment for locally advanced or recurrent rectal cancer. Proc Am Soc Clin Oncol 20: 555 (Abstract), 2001.
22. Tepper JE, O'Connel MJ, Petroni GR et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic irradiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 15: 2030-2039, 1997.
23. Fountzilas G, Zisiadis A, Dafni U et al: Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 10: 671-676, 1999.
24. National Cancer Institute. Clinical Announcement. Adjuvant therapy of rectal cancer, 1991.